Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06940427

Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis

Led by University of Wisconsin, Madison · Updated on 2026-03-11

50

Participants Needed

1

Research Sites

93 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to gain more information about how fibroblast activation protein inhibitor (FAPI) binds to a certain type of cells in fibrotic lung tissue and how this information can be used to better diagnose and track fibrotic lung disease activity. Participants will undergo up to 4 PET/MRI scans using the FAPI radiotracer.

CONDITIONS

Official Title

Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Able and willing to provide informed consent
  • Group A: Clinically evaluated for need to start new treatment, change current treatment, or add treatment for fibrotic hypersensitivity pneumonitis (HSP) or idiopathic pulmonary fibrosis (IPF)
  • Group B: Clinically stable without need to start or change treatment for fibrotic HSP or IPF
  • Crossover: Participants in Group B who later require new or changed treatment for fibrotic HSP or IPF
  • Willing and able to undergo PET/MRI
  • Participants may use mild oral anxiolytics if they have their own prescription, provide informed consent for use, and have a driver for the visit
Not Eligible

You will not qualify if you...

  • Unable or unwilling to provide informed consent
  • Pregnant
  • Contraindications to or inability to undergo PET/MRI
  • Contraindications to gadolinium-based contrast agents (GBCA), such as severe kidney disease or previously documented low kidney function (GFR < 30 ml/min/1.73 m2)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Wisconsin - Madison

Madison, Wisconsin, United States, 53705

Actively Recruiting

Loading map...

Research Team

R

Radiology Studies

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis | DecenTrialz